Evaluation of the immunomodulatory effect of gabexate mesilate in patients with severe acute pancreatitis

Current Therapeutic Research - Clinical and Experimental

Volumn 59, Issue 10, 1998, Pages 710-716

  Pezzilli, Raffaele ^a   Barakat, Bahjat ^a   Morselli labate, Antonio Maria ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute pancreatitis; C reactive protein; Gabexate; Placebo

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GABEXATE MESILATE;

ACUTE PANCREATITIS; ADULT; AGE; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; METABOLIC DISORDER; PANCREAS NECROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINASE INHIBITION; SEX DIFFERENCE;

EID: 0031786341     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(98)85029-7     Document Type: Article

References (33)

1. Tamura Y, Hirado M, Okamura K, et al. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r, and C1 esterase. Biochim Biophys Acta. 1978;484:417-422.
2. Freise J, Schmidt FW, Magerstedt P, Schmid K. Gabexate mesilate and camostate: New inhibitors of phospholipase A2 and their influence on the alfa-amylase activity in serum of patients with acute pancreatitis. Clin Biochem. 1985;18:224-229.
3. Kosaki G, Nomura T, Kambayashi J. The mechanism of the inhibitory effect of proteinase inhibitors on platelet aggregation and cellular synthesis of prostaglandins. I. The effect on the release of arachidonic acid from phospholipids. Thromb Res. 1980;20:587-598.
4. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. NEJM. 1996;335: 919-923.
5. Goebell H, for the German Pancreatitis Study Group. Multicenter double-blind study of gabexate-mesilate (Foy), given intravenously in low dose in acute pancreatitis. Digestion. 1988;40:83. Abstract.
6. Pederzoli P, Cavallini G, Falconi M, Bassi C. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.PA.). A prospective, randomized, double-blind multicenter study. Int J Pancreatol. 1993;14:117-124.
7. Valderrama R, Perez-Mateo M, Navarro S, et al. Multicenter double-blind trial of gabexate-mesilate (Foy) in unselected patients with acute pancreatitis. Digestion. 1992;51:65-70.
8. Buchler MW, Malfertheiner P, Uhl W, et al. Gabexate mesilate in human acute pancreatitis. Gastroenterology. 1993;104:1165-1170.
9. Messori A, Rampazzo R, Scroccaro G, et al. Effectiveness of gabexate mesilate in acute pancreatitis. A meta-analysis. Dig Dis Sci. 1995;40:734-738.
10. Scuderi P. Suppression of human leukocyte tumor necrosis factor secretion by the serine proteinase inhibitor p-toluenesulphonyl-L-arginine methyl ester (TAME). J Immunol. 1989;143:168-173.
11. Gearing AJH, Beckett R, Christidoulou M, et al. Processing of tumor necrosis factor-α precurson by metalloproteinases. Nature. 1994;370:555-557.
12. Kostura MJ, Tocci MJ, Limjuco G, et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA. 1989;86:5227-5231.
13. Wilson KP, Black JAF, Thomson JA, et al. Structure and mechanism of interleukin 1β converting enzyme. Nature. 1994;370:270-274.
14. Matsuda Y, Kawata S, Nagase T, et al. Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine proteinase inhibitor. Cancer. 1994;73:53-57.
15. Okumura Y, Inoue H, Fujiyama Y, Bamba T. Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol. 1995;30:379-386.
16. Ito N, Kawata S, Tamura S, et al. Induction of interleukin-6 by interferon alfa and its abrogation by a serine protease inhibitor in patients with chronic hepatitis C. Hepatology. 1996;23:669-675.
17. Agarwal N, Pitchumoni CS. Assessment of severity in acute pancreatitis. Am J Gastroenterol. 1991;86:1385-1391.
18. Uhl W, Buchler M, Malfertheiner P, et al. PNM-elastase in comparison with CRP, anti-proteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas. 1991;6:253-259.
19. Pezzilli R, Billi P, Platè L, et al. Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol. 1994;19:112-117.
20. Pezzilli R, Billi P, Miniero R, et al. Serum interleukin 6, interleukin 8 and β2 microglobulin in the early assessment of the severity of acute pancreatitis. A comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341-2348.
21. Pezzilli R, Billi P, Cappelletti O, Barakat B. Serum C-reactive protein in the acute biliary pancreatitis. Is it a reliable marker for the early assessment of severity of the disease? Ital J Gastroenterol Hepatol. 1997;29:554-557.
22. Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomised multi-centre clinical trial on antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480-483.
23. Neoptolemos JP, London NJ, James D, et al. Controlled trial of endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet. 1988; 1:979-983.
24. Pezzilli R, Billi P, Barakat B, et al. Effect of early ductal decompression in human acute pancreatitis. Pancreas. 1998;16:165-168.
25. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11-13, 1992. Arch Surg. 1993;128:586-590.
26. Turkey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley; 1977.
27. Siegel S. Non-parametric Statistics for the Behavioral Sciences. New York: McGraw-Hill; 1956.
28. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames: Iowa University Press; 1989.
29. Norusis MJ, SPSS Inc. SPSS/PC+ 4.0 Base and Advance Statistics Manuals. Chicago: SPSS Inc; 1990.
30. Leser HG, Gross V, Scheibenbogen C, et al. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology. 1991;101:782-785.
31. Le J, Vilcek J. Biology of disease. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 1989;61:588-602.
32. Van Laethem JL, Marchant A, Delvaux A, et al. Interleukin-10 prevents necrosis in murine experimental pancreatitis. Gastroenterology. 1995;188:1917-1922.
33. Curley P, Nestor M, Collins K, et al. Decreased interleukin-2 production in murine acute pancreatitis: Potential for immunomodulation. Gastroenterology. 1996;110:583-588.